+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Iobitrol Injection Market - Global Forecast 2026-2032- Product Image
Iobitrol Injection Market - Global Forecast 2026-2032- Product Image
Sale

Iobitrol Injection Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6147149
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Iobitrol Injection Market is projected to reach USD 225.90 Million in 2026. It is expected to continue growing at a CAGR of 9.65%, reaching USD 385.28 Million by 2032.

Iobitrol Injection: Executive Summary Scope and Clinical Context

Iobitrol injection is an iodinated contrast medium used to enhance visualization during diagnostic imaging procedures. Its use is shaped by imaging volumes, examination protocols, patient safety requirements, regulatory controls, procurement practices, and the availability of trained radiology personnel. This executive summary reviews the operating environment for Iobitrol injection without presenting market estimates, shares, forecasts, or company-specific comparisons.

How Imaging Practice and Safety Requirements Are Reshaping Use

The landscape is being transformed by wider adoption of cross-sectional imaging, greater emphasis on protocol standardization, and stricter controls for contrast administration. Healthcare providers are increasingly focused on screening for prior reactions, assessing renal risk, documenting informed consent where appropriate, and maintaining readiness for adverse-event management. Supply continuity, product traceability, storage compliance, and alignment with local prescribing and labeling requirements are also becoming central to institutional decision-making.

Artificial Intelligence Is Improving Imaging Workflows Around Contrast Use

Artificial intelligence is influencing contrast-enabled imaging primarily through workflow support rather than replacing clinical judgment. Algorithms can assist with examination prioritization, image-quality assessment, protocol selection, dose optimization, and detection of findings that may require urgent review. These applications may improve consistency and operational efficiency, but their value depends on validated performance, representative datasets, cybersecurity, interoperability with radiology systems, and clinician oversight. AI does not remove the need for patient-specific contraindication assessment or emergency preparedness.

Regional Insights: Regulation, Access, and Imaging Infrastructure Differ

North America generally emphasizes formal safety protocols, electronic documentation, and sophisticated imaging infrastructure, while Latin America shows greater variation in access, procurement capacity, and regional distribution. Europe places strong weight on harmonized regulatory expectations, pharmacovigilance, and evidence-based imaging practice. The Middle East is characterized by investment in advanced healthcare facilities alongside differences between national systems, whereas Africa faces uneven access to imaging equipment, specialist personnel, and reliable supply chains. Asia-Pacific combines technologically advanced imaging centers with substantial differences in healthcare coverage, regulatory systems, and rural access. Across all regions, responsible use depends on trained staff, quality-assured products, and reliable emergency response capabilities.

Group Insights: Multilateral and Economic Blocs Shape Operating Priorities

ASEAN markets reflect varied regulatory maturity, healthcare financing, and access to specialized imaging. BRICS members encompass large and diverse healthcare systems in which public procurement, domestic manufacturing capacity, and uneven regional access can strongly influence availability. The European Union emphasizes coordinated regulatory principles, quality systems, and cross-border consistency. G7 countries generally have mature imaging networks, established pharmacovigilance processes, and strong expectations for clinical governance. GCC states are expanding advanced diagnostic capacity while aligning procurement and regulatory practices across interconnected health systems. NATO members span different healthcare structures, but continuity planning, resilient supply chains, and preparedness for operational disruption are recurring priorities.

Country Insights: National Practice Depends on Regulation and Health-System Capacity

Australia and Canada combine structured healthcare governance with geographically dispersed service delivery. Brazil, Mexico, India, China, and Russia present large and diverse systems where urban-rural differences, public procurement, and local production or distribution capabilities can affect access. France, Germany, Italy, Spain, and the United Kingdom operate within mature regulatory and clinical environments, with attention to safety monitoring, procurement value, and protocol consistency. Japan and South Korea have advanced imaging capabilities and strong quality expectations, while the United States has extensive use of diagnostic imaging supported by detailed institutional protocols and regulatory oversight. Across these countries, safe administration requires adherence to approved labeling, patient screening, dose control, and documented response procedures.

Actions for Leaders: Strengthen Safety, Supply Resilience, and Clinical Integration

Industry leaders should maintain robust quality systems, monitor regulatory changes, and support clear training for contrast selection, administration, and adverse-event response. Healthcare organizations should standardize patient screening, renal-risk assessment, reaction-management protocols, documentation, and post-procedure follow-up. Procurement teams should use multisource continuity planning where permitted, verify product traceability, and coordinate inventory with imaging demand. Leaders adopting AI should require clinical validation, transparent performance monitoring, interoperability testing, cybersecurity controls, and clear accountability for human review. Education and service support should be adapted to local workforce capacity and infrastructure constraints.

Research Methodology: Evidence-Based Review of the Iobitrol Injection Environment

This executive summary uses the supplied market subject- Iobitrol injection-as the analytical scope and synthesizes established considerations relevant to iodinated contrast media, including clinical use, patient safety, imaging workflow, regulation, procurement, infrastructure, and digital transformation. Regional, group, and country observations are framed as qualitative system-level insights rather than numerical market claims. The assessment excludes market estimates, market sizing, market shares, forecasts, and company comparisons, and should be supplemented with current local labeling, clinical guidance, and regulatory documentation before operational decisions are made.

Conclusion: Safe, Reliable Contrast Use Depends on Integrated Clinical Governance

The operating environment for Iobitrol injection is defined by the interaction of diagnostic imaging demand, safety governance, regulatory compliance, supply reliability, and workforce capability. Regional and national differences affect how these priorities are implemented, but the core requirements remain consistent: use within approved indications, careful patient assessment, standardized administration, preparedness for adverse reactions, and continuous quality improvement. Artificial intelligence can enhance workflow and consistency when deployed responsibly, while clinical accountability remains essential.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Iobitrol Injection Market, by Route Of Administration
7.1. Introduction
7.2. Intra-Arterial
7.3. Intrathecal
7.4. Intravenous
8. Iobitrol Injection Market, by Dosage Form
8.1. Introduction
8.2. Multi Dose Vial
8.3. Prefilled Syringe
8.4. Single Dose Vial
9. Iobitrol Injection Market, by Application
9.1. Introduction
9.2. Angiography
9.3. Computed Tomography Imaging
9.4. Fluoroscopy Imaging
9.5. Urography
10. Iobitrol Injection Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centres
10.3. Clinics
10.4. Diagnostic Centres
10.5. Hospitals
10.6. Radiology Centers
11. Iobitrol Injection Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Iobitrol Injection Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Iobitrol Injection Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Iobitrol Injection Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AbbVie Inc.
16.2. Accord Healthcare
16.3. Alkem Laboratories Ltd.
16.4. Amneal Pharmaceuticals Pvt. Ltd.
16.5. Bayer AG
16.6. Bracco Imaging S.p.A.
16.7. Chiesi Farmaceutici S.p.A.
16.8. Cipla Ltd.
16.9. Dr. Reddy’s Laboratories Ltd.
16.10. Endo International plc
16.11. Fresenius Kabi AG
16.12. Fujifilm Holdings Corporation
16.13. Guerbet Group
16.14. Hikma Pharmaceuticals PLC
16.15. Hospira, Inc. (Pfizer)
16.16. Intas Pharmaceuticals Ltd.
16.17. Iopharm GmbH
16.18. Lantheus Medical Imaging, Inc.
16.19. LGM Pharma Pvt. Ltd.
16.20. Mallinckrodt Pharmaceuticals
16.21. Medice Arzneimittel Pütter GmbH & Co. KG
16.22. Mylan Laboratories Ltd.
16.23. Nicholas Piramal India Ltd.
16.24. Sagent Pharmaceuticals, Inc.
16.25. Sandoz International GmbH
16.26. Sanochemia Pharmazeutika AG
16.27. Siegfried AG
16.28. Sun Pharmaceutical Industries Ltd.
16.29. Wockhardt Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Iobitrol Injection Market, Years Considered for the Study
FIGURE 2. Global Iobitrol Injection Market, Research Design
FIGURE 3. Global Iobitrol Injection Market, Research Framework
FIGURE 4. Global Iobitrol Injection Market, Data Triangulation
FIGURE 5. Global Iobitrol Injection Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Iobitrol Injection Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 7. Global Iobitrol Injection Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Iobitrol Injection Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 9. Global Iobitrol Injection Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Iobitrol Injection Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Iobitrol Injection Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Iobitrol Injection Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Iobitrol Injection Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Iobitrol Injection Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Iobitrol Injection Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Iobitrol Injection Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Iobitrol Injection Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Iobitrol Injection Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Iobitrol Injection Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Iobitrol Injection Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Iobitrol Injection Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Iobitrol Injection Market Segmentation & Coverage
TABLE 2. Global Iobitrol Injection Market Size, 2017-2032 (USD Million)
TABLE 3. Global Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 4. Global Intra-Arterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Intra-Arterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Intra-Arterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Intrathecal Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Intrathecal Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Intrathecal Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 14. Global Multi Dose Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Multi Dose Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Multi Dose Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Prefilled Syringe Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Prefilled Syringe Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Prefilled Syringe Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Single Dose Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Single Dose Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Single Dose Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 24. Global Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Computed Tomography Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Computed Tomography Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Computed Tomography Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Fluoroscopy Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Fluoroscopy Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Fluoroscopy Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Urography Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Urography Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Urography Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 37. Global Ambulatory Care Centres Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Ambulatory Care Centres Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Ambulatory Care Centres Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Diagnostic Centres Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Diagnostic Centres Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Diagnostic Centres Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Radiology Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Radiology Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Radiology Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 53. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Iobitrol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Iobitrol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 66. North America Iobitrol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. North America Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 68. North America Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 69. North America Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 70. North America Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. North America Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 72. Latin America Iobitrol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Latin America Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 74. Latin America Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 75. Latin America Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. Latin America Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. Latin America Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 78. Europe Iobitrol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Europe Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 80. Europe Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 81. Europe Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 82. Europe Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Europe Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 84. Middle East Iobitrol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Middle East Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 86. Middle East Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 87. Middle East Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. Middle East Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 89. Middle East Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. Africa Iobitrol Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Africa Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 92. Africa Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 93. Africa Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. Africa Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Africa Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 96. Global Iobitrol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. ASEAN Iobitrol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. ASEAN Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 99. ASEAN Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 100. ASEAN Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 101. ASEAN Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. ASEAN Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 103. GCC Iobitrol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. GCC Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 105. GCC Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 106. GCC Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. GCC Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. GCC Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 109. European Union Iobitrol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. European Union Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 111. European Union Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 112. European Union Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. European Union Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. European Union Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. BRICS Iobitrol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. BRICS Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 117. BRICS Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 118. BRICS Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. BRICS Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. BRICS Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 121. G7 Iobitrol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. G7 Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 123. G7 Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 124. G7 Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. G7 Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. G7 Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. NATO Iobitrol Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. NATO Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 129. NATO Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 130. NATO Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. NATO Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. NATO Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 133. Global Iobitrol Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. United States Iobitrol Injection Market Size, 2017-2032 (USD Million)
TABLE 135. United States Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 136. United States Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 137. United States Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. United States Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. United States Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 140. Canada Iobitrol Injection Market Size, 2017-2032 (USD Million)
TABLE 141. Canada Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 142. Canada Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 143. Canada Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. Canada Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Canada Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. Mexico Iobitrol Injection Market Size, 2017-2032 (USD Million)
TABLE 147. Mexico Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 148. Mexico Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 149. Mexico Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. Mexico Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. Mexico Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. Brazil Iobitrol Injection Market Size, 2017-2032 (USD Million)
TABLE 153. Brazil Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 154. Brazil Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 155. Brazil Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. Brazil Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Brazil Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 158. United Kingdom Iobitrol Injection Market Size, 2017-2032 (USD Million)
TABLE 159. United Kingdom Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 160. United Kingdom Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 161. United Kingdom Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. United Kingdom Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. United Kingdom Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. Germany Iobitrol Injection Market Size, 2017-2032 (USD Million)
TABLE 165. Germany Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 166. Germany Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 167. Germany Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. Germany Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 169. Germany Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 170. France Iobitrol Injection Market Size, 2017-2032 (USD Million)
TABLE 171. France Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 172. France Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 173. France Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. France Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. France Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 176. Russia Iobitrol Injection Market Size, 2017-2032 (USD Million)
TABLE 177. Russia Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 178. Russia Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 179. Russia Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. Russia Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Russia Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. Italy Iobitrol Injection Market Size, 2017-2032 (USD Million)
TABLE 183. Italy Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 184. Italy Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 185. Italy Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. Italy Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. Italy Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. Spain Iobitrol Injection Market Size, 2017-2032 (USD Million)
TABLE 189. Spain Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 190. Spain Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 191. Spain Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. Spain Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Spain Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 194. China Iobitrol Injection Market Size, 2017-2032 (USD Million)
TABLE 195. China Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 196. China Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 197. China Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. China Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. China Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 200. India Iobitrol Injection Market Size, 2017-2032 (USD Million)
TABLE 201. India Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 202. India Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 203. India Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. India Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. India Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. Japan Iobitrol Injection Market Size, 2017-2032 (USD Million)
TABLE 207. Japan Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 208. Japan Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 209. Japan Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. Japan Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. Japan Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. Australia Iobitrol Injection Market Size, 2017-2032 (USD Million)
TABLE 213. Australia Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 214. Australia Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 215. Australia Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. Australia Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. Australia Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 218. South Korea Iobitrol Injection Market Size, 2017-2032 (USD Million)
TABLE 219. South Korea Iobitrol Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 220. South Korea Iobitrol Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 221. South Korea Iobitrol Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. South Korea Iobitrol Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. South Korea Iobitrol Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 224. Global Iobitrol Injection Market Share, by Key Player, 2025
TABLE 225. Global Iobitrol Injection Market, Key Experts

Companies Mentioned

  • AbbVie Inc.
  • Accord Healthcare
  • Alkem Laboratories Ltd.
  • Amneal Pharmaceuticals Pvt. Ltd.
  • Bayer AG
  • Bracco Imaging S.p.A.
  • Chiesi Farmaceutici S.p.A.
  • Cipla Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Endo International plc
  • Fresenius Kabi AG
  • Fujifilm Holdings Corporation
  • Guerbet Group
  • Hikma Pharmaceuticals PLC
  • Hospira, Inc. (Pfizer)
  • Intas Pharmaceuticals Ltd.
  • Iopharm GmbH
  • Lantheus Medical Imaging, Inc.
  • LGM Pharma Pvt. Ltd.
  • Mallinckrodt Pharmaceuticals
  • Medice Arzneimittel Pütter GmbH & Co. KG
  • Mylan Laboratories Ltd.
  • Nicholas Piramal India Ltd.
  • Sagent Pharmaceuticals, Inc.
  • Sandoz International GmbH
  • Sanochemia Pharmazeutika AG
  • Siegfried AG
  • Sun Pharmaceutical Industries Ltd.
  • Wockhardt Ltd.

Related Topics

Related Reports

Carbon Nanoparticles Suspension Injection Market - Global Forecast 2026-2032 - Product Image

Carbon Nanoparticles Suspension Injection Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Potassium Dehydroandrographolide Succinate Injection Market - Global Forecast 2026-2032 - Product Image

Potassium Dehydroandrographolide Succinate Injection Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Insulin Injection Aids - Global Strategic Business Report - Product Image

Insulin Injection Aids - Global Strategic Business Report

  • Report
  • 280 Pages
  • Global
From
Injection Pens - Global Strategic Business Report - Product Image

Injection Pens - Global Strategic Business Report

  • Report
  • 355 Pages
  • Global
From
Self-Injections Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Self-Injections Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.